Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide
TM Robinson, PV O'Donnell, EJ Fuchs, L Luznik - Seminars in hematology, 2016 - Elsevier
Allogeneic blood or bone marrow transplantation (BMT) is a potentially curative therapy for
high-risk hematologic malignancies not curable by standard chemotherapy, but the …
high-risk hematologic malignancies not curable by standard chemotherapy, but the …
How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide
SR McCurdy, L Luznik - Hematology 2014, the American …, 2019 - ashpublications.org
HLA-haploidentical hematopoietic stem cell transplantation is now one of the most
commonly employed alternative donor techniques, with most centers applying T-cell–replete …
commonly employed alternative donor techniques, with most centers applying T-cell–replete …
Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell–replete haploidentical donor transplantation using post-transplant …
A Bashey, MJ Zhang, SR McCurdy… - Journal of Clinical …, 2017 - ascopubs.org
Purpose T-cell–replete HLA-haploidentical donor hematopoietic transplantation using post-
transplant cyclophosphamide was originally described using bone marrow (BM). With …
transplant cyclophosphamide was originally described using bone marrow (BM). With …
Bone marrow versus mobilized peripheral blood stem cells in haploidentical transplants using posttransplantation cyclophosphamide
BACKGROUND Incidence of graft‐versus‐host disease (GVHD) in haploidentical bone
marrow (BM) transplants using posttransplantion cyclophosphamide (PT‐Cy) is low …
marrow (BM) transplants using posttransplantion cyclophosphamide (PT‐Cy) is low …
[HTML][HTML] Sources of hematopoietic stem and progenitor cells and methods to optimize yields for clinical cell therapy
SR Panch, J Szymanski, BN Savani… - Biology of Blood and …, 2017 - Elsevier
Bone marrow (BM) aspirates, mobilized peripheral blood, and umbilical cord blood (UCB)
have developed as graft sources for hematopoietic stem and progenitor cells (HSPCs) for …
have developed as graft sources for hematopoietic stem and progenitor cells (HSPCs) for …
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
S Piemontese, F Ciceri, M Labopin, W Arcese… - Journal of hematology & …, 2017 - Springer
Background In the absence of a HLA-matched related or matched unrelated donor,
allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or …
allogeneic stem cell transplantation (allo-SCT) from mismatched unrelated donors or …
Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant
DJ Gottlieb, LE Clancy, B Withers… - Clinical & …, 2021 - Wiley Online Library
Objectives Adoptive immunotherapy using donor‐derived antigen‐specific T‐cells can
prevent and treat infection after allogeneic haemopoietic stem cell transplant (HSCT) …
prevent and treat infection after allogeneic haemopoietic stem cell transplant (HSCT) …
Bone marrow versus mobilized peripheral blood stem cell graft in T-cell-replete haploidentical transplantation in acute lymphoblastic leukemia
The ideal stem cell graft source remains unknown in haploidentical haematopietic cell
transplantation (haplo-HCT) with posttransplantation cyclophosphamide (PTCy). This study …
transplantation (haplo-HCT) with posttransplantation cyclophosphamide (PTCy). This study …
[HTML][HTML] Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia-a report from the …
A significant proportion of hematopoietic stem cell transplants are performed with ABO-
mismatched donors. The impact of ABO mismatch on outcome following transplantation …
mismatched donors. The impact of ABO mismatch on outcome following transplantation …
Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide—a systematic …
X Yu, L Liu, Z Xie, C Dong, L Zhao, J Zhang… - Critical Reviews in …, 2019 - Elsevier
Background Peripheral-blood (PB) and bone marrow (BM) are both widely used in
hematopoietic stem cell transplantation (HSCT). However, it is unclear whether PB or BM …
hematopoietic stem cell transplantation (HSCT). However, it is unclear whether PB or BM …